# Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Article · Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart, Jean G. MacFadyen, Elaine Zaharris, Brendan M. Everett, Stuart E. Campbell, Ryu Oshima, Pierre Amarenco, Dirk Jacobus Blom, Eliot A. Brinton, Robert H. Eckel, Marshall B. Elam, João Soares Felício, Henry N. Ginsberg, Assen Goudev, Shun Ishibashi, Jacob Joseph, Tatsuhiko Kodama, Wolfgang Köenig, Lawrence A. Leiter, Alberto J. Lorenzatti, Boris Mankovsky, Nikolaus Marx, Børge Grønne Nordestgaard and 11 more

- Archive id: doi:10.1056/nejmoa2210645
- Published: 2022-11-05
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2210645
- PMID: 36342113
- Citations: 746
- Source URL: https://doi.org/10.1056/nejmoa2210645
- PDF: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2210645?articleTools=true
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

Cited in dossiers:
- [Cardiovascular Therapeutics: State of the Field (October 2026)](https://space-kitty.com/dossiers/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.